![Perry Sternberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perry Sternberg
Directeur/Membre du Conseil chez
HARROW, INC.
Fortune : - $ au 31/05/2026
Profil
Perry J.
Sternberg is Chief Executive Officer & Director at Sydnexis, Inc. since 2024.
Mr. Sternberg is Lead Independent Director at Harrow, Inc. since 2022.
Mr. Sternberg is Director at Surface Ophthalmics, Inc. Formerly, Mr. Sternberg was President & Chief Executive Officer at Corium LLC (Massachusetts) from 2019 to 2024.
Mr. Sternberg was Chief Executive Officer at Corium Innovations, Inc. Mr. Sternberg was President, Chief Executive Officer & Director at Corium LLC.
Mr. Sternberg was Head-Neuroscience Business Unit at Shire Plc from 2013 to 2019.
Mr. Sternberg was Vice President & General Manager at Bausch & Lomb, Inc. Mr. Sternberg completed undergraduate studies at The Pennsylvania State University in 1990.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
HARROW, INC. -.--% | 18/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Perry Sternberg
| Sociétés | Poste | Début |
|---|---|---|
| HARROW, INC. | Directeur/Membre du Conseil | 31/03/2022 |
Surface Ophthalmics, Inc.
 Surface Ophthalmics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focuses on development and commercialization of therapeutics | Directeur/Membre du Conseil | - |
Sydnexis, Inc.
 Sydnexis, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur Général | 05/08/2024 |
Anciens postes connus de Perry Sternberg
| Sociétés | Poste | Fin |
|---|---|---|
| CORIUM INTERNATIONAL INC | Directeur Général | 01/07/2024 |
Corium Pharma Solutions, Inc.
 Corium Pharma Solutions, Inc. Medical SpecialtiesHealth Technology Operates as a biopharmaceutical contract development and manufacturing organization that develops transdermal patches & oral thin-film systems | Directeur Général | 17/01/2023 |
| SHIRE | Corporate Officer/Principal | 01/01/2019 |
Bausch & Lomb, Inc. /Miracle-Ear Hearing Aid Business/
 Bausch & Lomb, Inc. /Miracle-Ear Hearing Aid Business/ Medical SpecialtiesHealth Technology Manufactures and markets hearing aids and related products | Corporate Officer/Principal | - |
Corium LLC
 Corium LLC BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in the development and commercialization of novel neuroscience therapies | Directeur Général | - |
Formation de Perry Sternberg
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
67
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Bausch & Lomb, Inc. /Miracle-Ear Hearing Aid Business/
Bausch & Lomb, Inc. /Miracle-Ear Hearing Aid Business/ Medical SpecialtiesHealth Technology Manufactures and markets hearing aids and related products | Health Technology |
The Pennsylvania State University
 The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Corium International, Inc.
 Corium International, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of novel neuroscience therapies | Health Technology |
Harrow, Inc.
 Harrow, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development, production, and sale of innovative medications | Health Technology |
Sydnexis, Inc.
Sydnexis, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Surface Ophthalmics, Inc.
Surface Ophthalmics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focuses on development and commercialization of therapeutics | Health Technology |
Corium Pharma Solutions, Inc.
Corium Pharma Solutions, Inc. Medical SpecialtiesHealth Technology Operates as a biopharmaceutical contract development and manufacturing organization that develops transdermal patches & oral thin-film systems | Health Technology |
Corium LLC
Corium LLC BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in the development and commercialization of novel neuroscience therapies | Health Technology |
Choisissez Zonebourse 
